Visalytics
Visalytics
approved EB-2 (NIW)

Research Scientist

Biomedical Science · South Korea · 2024-01-30

Processing Time
5 days
Decision Date
2024-01-30
Location
Massachusetts
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue her research elucidating the role of innate immune signaling and cell-type-specific pathway regulation in neurodegenerative diseases. Her work focuses on developing next-generation diagnostics and therapeutics to improve treatment interventions and reduce side effects for patients with neurological disorders.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The research significantly advances the detection and treatment of neurodegenerative diseases, which is of great importance to the U.S.

2 Well-positioned to Advance the Endeavor Met

With 12 publications and over 3,200 citations, the petitioner has a proven record of influencing the biomedical science field.

3 Waiver of Job Offer and Labor Certification Met

The research lessens the consequences of neurological illnesses on patients and families, providing a clear benefit to the U.S. economy and public health.

Why This Petition Was Approved

The petition was approved based on the petitioner's 12 peer-reviewed journal articles published in highly ranked journals and a significant citation count of 3,242. Additionally, her work received funding from 18 eminent organizations, demonstrating its national importance and her well-positioned status to advance the endeavor under the Dhanasar framework.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Grants
Original Contributions

Similar Cases

Doctor

Biotechnology · China

WeGreened EB-2 (NIW) rfe approved
484 days 2025-10-31
The petitioner proposes to continue critical research using cellular and molecular techniques to elucidate the mechanisms of neurodegenerative diseases. This work aims to facilitate the development of new and improved prognostic and diagnostic tools for medical applications.
View Case

Scientist

Biotechnology · India

WeGreened EB-2 (NIW) approved
New York 106 days 2023-01-28
The petitioner proposes to elucidate the genetic mechanisms underlying neurodegenerative diseases using expertise in biochemistry, genetics, and molecular biology. The work focuses on identifying new biological targets for the treatment of Alzheimer’s disease, Parkinson’s disease, and other dementias to provide insights into neuronal degeneration.
View Case

Postdoctoral Researcher

Research and Development · Taiwan

WeGreened EB-2 (NIW) approved
Connecticut 90 days 2023-01-19
The petitioner proposes to continue her research on developing novel therapies for neurodegenerative diseases by employing advanced electrophysiological and genetic manipulation techniques. Her work focuses on uncovering neurodegenerative mechanisms to improve therapeutic outcomes for conditions such as Huntington’s, Alzheimer’s, and Parkinson’s disease.
View Case

Scientist

Research and Development · China

WeGreened EB-2 (NIW) approved
California 474 days 2025-03-07
The petitioner proposes to continue research into the cellular and molecular mechanisms of learning and memory to identify new therapeutic targets for neurodegenerative conditions like Alzheimer’s and Parkinson’s disease. The work involves identifying specific neuronal dynamics and molecular mechanisms to decrease mortality and reduce national healthcare expenditures associated with neurological disorders.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from South Korea

Case data sourced from publicly available petition decisions and case studies. Decision date: 2024-01-30.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 5 days
Criteria Met 3 / 3
Evidence Types 4

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in South Korea All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist